Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

Early detection and prevention of neonatal encephalopathy using BIND score.

Not Yet Recruiting

Trial opening soon.

Key information

Conditions

Neonatal Hyperbilirubinemia Congenital, Hereditary, and Neonatal Diseases and Abnormalities Hyperbilirubinemia Hyperbilirubinemia, Neonatal Infant, Newborn, Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

1 day–28 day

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Newborn < 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion

Exclusion criteria

Age > 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).

Treatment and study plan

Phototherapy

Device

Phototherapy used to decrease high billirubin level in neonatal jaundice

Primary outcomes

Decrease high billirubin level

Time frame: One year duration

We use bind score to evaluate neurological condition of neoborns then use photo therapy to decrease
Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Time frame: Baseline

Early detection and prevention of neonatal encephalopathy using BIND score.
Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Time frame: Baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Nouralhoda Ahmed Metwally

CONTACT

[email protected]

+201012527376

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in NICU

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Sep 2, 2025
Registry last updated: Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting